INS and metabolic dysfunction-associated steatohepatitis: Hepatic inflammation mediated by M1-like liver macrophage-derived ROS, cytokines, and chemokines in NASH promotes lipogenesis by inhibiting insulin signaling and activation of SREBP [25, 34, 35].